Recent regulatory changes and technological advances are leading pharmaceutical manufacturers to consider new technologies for microbial air monitoring. EU GMP Annex 1 requires continuous viable air monitoring in Grade A environments for the full duration of critical processing, and its recent revision has changed regulatory attitudes toward real-time detection. Manufacturing is evolving, too: novel biologicals are increasingly being produced with minimal operator intervention in gloved or even gloveless isolators.
These developments have catalyzed broader interest in advanced biofluorescent particle counters (BFPCs) for fluorescence-based continuous active air monitoring in real-time, available in combination with integrated traditional microbial air sampling onto plates. In this webinar, our panel of environmental monitoring specialists will discuss in which settings a BFPC can streamline workflows to boost manufacturing productivity while meeting present and future regulatory demands, and the challenges that need to be overcome.
During the webinar, you will:
- Discover real-time air monitoring in Grade A environments under the latest EU Annex 1.
- Learn how BFPCs pair with traditional sampling to enable real-time decisions.
- Understand regulatory, validation, and operational challenges.
- Explore practical options for integration, qualification, and cost/benefit considerations.
To register go to: BFPCs.
Pharmaceutical Microbiology Resources (http://www.pharmamicroresources.com/)